Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for ...
Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
Nearly 60% of randomized trial abstracts were improved after peer review, according to blinded independent reviewers. Among abstracts that were eventually published in top medical journals, 72% ...